Literature DB >> 24449314

Will detection of microRNA biomarkers in blood improve the diagnosis and survival of patients with pancreatic cancer?

Donald J Buchsbaum1, Carlo M Croce2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24449314      PMCID： PMC4161014          DOI： 10.1001/jama.2013.284665

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   157.335


× No keyword cloud information.
  12 in total

Review 1.  Targeting microRNAs in pancreatic cancer: microplayers in the big game.

Authors:  Sheema Khan; Deepak Kumar; Meena Jaggi; Subhash C Chauhan
Journal:  Cancer Res       Date:  2013-11-07       Impact factor: 12.701

2.  FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

Authors:  Thierry Conroy; Françoise Desseigne; Marc Ychou; Olivier Bouché; Rosine Guimbaud; Yves Bécouarn; Antoine Adenis; Jean-Luc Raoul; Sophie Gourgou-Bourgade; Christelle de la Fouchardière; Jaafar Bennouna; Jean-Baptiste Bachet; Faiza Khemissa-Akouz; Denis Péré-Vergé; Catherine Delbaldo; Eric Assenat; Bruno Chauffert; Pierre Michel; Christine Montoto-Grillot; Michel Ducreux
Journal:  N Engl J Med       Date:  2011-05-12       Impact factor: 91.245

3.  MicroRNA biomarkers in whole blood for detection of pancreatic cancer.

Authors:  Nicolai A Schultz; Christian Dehlendorff; Benny V Jensen; Jon K Bjerregaard; Kaspar R Nielsen; Stig E Bojesen; Dan Calatayud; Svend E Nielsen; Mette Yilmaz; Niels Henrik Holländer; Klaus K Andersen; Julia S Johansen
Journal:  JAMA       Date:  2014 Jan 22-29       Impact factor: 56.272

4.  MicroRNA alterations of pancreatic intraepithelial neoplasias.

Authors:  Jun Yu; Ang Li; Seung-Mo Hong; Ralph H Hruban; Michael Goggins
Journal:  Clin Cancer Res       Date:  2011-11-23       Impact factor: 12.531

5.  Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer.

Authors:  Jianqiang Liu; Jun Gao; Yiqi Du; Zhaoshen Li; Yan Ren; Junjun Gu; Xiaowei Wang; Yanfang Gong; Weiwei Wang; Xiangyu Kong
Journal:  Int J Cancer       Date:  2011-11-19       Impact factor: 7.396

Review 6.  Epidemiology of pancreatic cancer: an update.

Authors:  Patrick Maisonneuve; Albert B Lowenfels
Journal:  Dig Dis       Date:  2010-11-18       Impact factor: 2.404

Review 7.  The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates.

Authors:  Katherine E Poruk; D Z Gay; K Brown; J D Mulvihill; K M Boucher; C L Scaife; M A Firpo; S J Mulvihill
Journal:  Curr Mol Med       Date:  2013-03       Impact factor: 2.222

8.  Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial.

Authors:  Helmut Oettle; Peter Neuhaus; Andreas Hochhaus; Jörg Thomas Hartmann; Klaus Gellert; Karsten Ridwelski; Marco Niedergethmann; Carl Zülke; Jörg Fahlke; Michael B Arning; Marianne Sinn; Axel Hinke; Hanno Riess
Journal:  JAMA       Date:  2013-10-09       Impact factor: 56.272

Review 9.  Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine.

Authors:  Yantian Fang; Qizhi Yao; Zongyou Chen; Jianbin Xiang; Fisher E William; Richard A Gibbs; Changyi Chen
Journal:  Med Sci Monit       Date:  2013-10-31

10.  MicroRNA in Aging: From Discovery to Biology.

Authors:  Hwa Jin Jung; Yousin Suh
Journal:  Curr Genomics       Date:  2012-11       Impact factor: 2.236
View more
  5 in total

1.  Uncovering the pathogenesis and identifying novel targets of pancreatic cancer using bioinformatics approach.

Authors:  Li-Li Zhao; Tong Zhang; Li-Wei Zhuang; Bing-Zhu Yan; Rui-Feng Wang; Bing-Rong Liu
Journal:  Mol Biol Rep       Date:  2014-04-12       Impact factor: 2.316

2.  A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile.

Authors:  Gregory A Cote; A Jesse Gore; Samantha D McElyea; Laura E Heathers; Huiping Xu; Stuart Sherman; Murray Korc
Journal:  Am J Gastroenterol       Date:  2014-10-28       Impact factor: 10.864

Review 3.  Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer.

Authors:  Robert Słotwiński; Sylwia Małgorzata Słotwińska
Journal:  Cent Eur J Immunol       Date:  2017-01-24       Impact factor: 2.085

4.  Challenges in detecting pre-malignant pancreatic lesions during acute pancreatitis using a serum microRNA assay: a study based on KrasG12D transgenic mice.

Authors:  Xiafei Hong; Jie Zhang; Qiao Wu; Wenze Wang; Adam Yongxin Ye; Wei Song; Hongmei Dai; Xianze Wang; Fan Wu; Lei You; Wenming Wu; Yupei Zhao
Journal:  Oncotarget       Date:  2016-04-19

5.  miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson's disease.

Authors:  Xiaoting Liu; Jinhu Chen; Tianyuan Guan; Hui Yao; Wenpei Zhang; Zhenlong Guan; Yanqin Wang
Journal:  BMC Syst Biol       Date:  2019-01-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.